2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
8
Recruiting
8
Terminated
7
Completed
7
Active not recruiting
5
Withdrawn
2
Not yet recruiting
1
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Conditions
Breast Neoplasms
549
Neoplasms
384
Carcinoma, Non-Small-Cell Lung
319
Colorectal Neoplasms
290
Lung Neoplasms
239
Prostatic Neoplasms
219
Carcinoma, Hepatocellular
212
Stomach Neoplasms
158
Pancreatic Neoplasms
151
Leukemia, Myeloid, Acute
139
Multiple Myeloma
130
Uterine Cervical Neoplasms
127
Recurrence
116
Rectal Neoplasms
112
Ovarian Neoplasms
105
Neoplasm Metastasis
104
Squamous Cell Carcinoma of Head and Neck
97
Head and Neck Neoplasms
89
Esophageal Neoplasms
85
Triple Negative Breast Neoplasms
84
Glioblastoma
80
Small Cell Lung Carcinoma
79
Endometrial Neoplasms
79
Colonic Neoplasms
78
Brain Neoplasms
78
Melanoma
69
Precursor Cell Lymphoblastic Leukemia-Lymphoma
66
Hematologic Neoplasms
64
Glioma
62
Motor Activity
60
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Liposarcoma, Myxoid
×
Clear all
NCT06748872
2024-12-27
EPITOME-1015-I
Medigene AG
Phase 1
Not yet recruiting
55 enrolled